November 27, 2014 3:16 PM ET

Hotels, Restaurants and Leisure

Company Overview of Znomics, Inc.

Executive Profile

Roy G. Smith Ph.D.

Member of Advisory Board, AV Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Dr. Roy G. Smith, Ph.D. serves as Chairman and Chief Scientific Officer of Rejuvenon Corp. He serves as a Professor in the Department of Molecular and Cellular Biology and Professor in the Department of Medicine. Dr. Smith founded Helsinn Therapeutics (US) Inc. (also called as Sapphire Therapeutics Inc.) in 2000 and served as its Chief Scientific Officer. From 1987 to 1998, he served as Scientific Leader of Merck & Co. In 1987, he joined Merck & Co. where he served as ...

Corporate Headquarters

9531 West 78th Street
Eden Prairie, Minnesota 55344

United States

Phone: 701-651-3011
Fax: --

Board Members Memberships



Post-Doctoral Training
Vanderbilt University
PhD 1970
Queen Mary
Unknown/Other Education
Royal Institute Of Chemistry UK

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Znomics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at